Re: French bean counters weigh herceptin vs lapatinib
Sometimes insurance companies get away with this kind of stupidity. I hope they get fired.
Also, if Insurance companies fund research, their only motive is to reduce costs in the long run, so researchers who are enjoying the funding may be tempted to come up with results that are company-friendly.
A disgrace!
Jacqueline
__________________
Diagnosed age 44, January 2004, 0.7 cm IDC & DCIS. Stage 1, grade 3, ER/PR pos. HER2 pos. clear margins, no nodes. SNB. 35 rads. On Zoladex and Armidex since Dec. 2004. Stopped Zoladex/Arimidex sept 2009 Still taking mistletoe shots (CAM therapy) Doing fine.
|